• ProCan Project to Advance Proteome Studies at CMRI
    From left to right: Prof. Phil Robinson (Head of Cell Signaling Unit and co-developer of ProCan), Valentina Valova (Manager of Biomedical Proteomics Facility and ProCan, CMRI), Prof. Roger Reddel (Director of CMRI and Head of Cancer research Unit) and Dr. Christie Hunter (SCIEX Director of OMICs Applications).

    News

    ProCan Project to Advance Proteome Studies at CMRI

    The Children’s Medical Research Institute (CMRI), through an alliance with life science analytical technologies company SCIEX has announced the opening of ProCanTM , the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer. Established with a $10 million grant from the Australian Cancer Research Foundation, the partnership will enable large-scale proteome studies helping to industrialise the process of analysing tissue samples and identifying cancer biomarkers. The opening of the Centre was marked by the ProCan Industrialised Proteomics Centre Symposium, highlights of which can be accessed in the SCIEX online symposium portal.

    Research will be carried out on a suite of SCIEX TripleTOF® systems using a tissue-based method developed at Ruedi Aebersold's lab at the ETH, Zurich* which will profile thousands of tumour samples per year, to identify and develop markers of disease risk, diagnosis, response to therapy, and prognosis on an industrial scale, while developing standard operating procedures for other facilities worldwide. Exclusive collaborators, include Pressure Biosciences (PBIO) and Beckman Coulter, using pressure cycling technology and liquid handling workstations for increased sample preparation, throughput, and reproducibility.

    "This collaboration with SCIEX enables ProCan to advance our vision to scale-up the process of finding causes of cancers, which is essential for earlier diagnosis and the development of new and even personalised approaches," said Professor Phil Robinson, Head of the Cell Signalling Unit at CMRI and co-developer of ProCan. "The opening of this centre isn’t just an exciting milestone for us and for SCIEX, but it’s exciting for the advancement of precision medicine at-large, as the information generated by ProCan will ultimately be free for anyone to access, helping scientists all around the world with rapid diagnoses and treatment planning."

    Jean-Paul Mangeolle, President of SCIEX states, "Many years of partnerships and work have helped bring ProCan to fruition. Working closely with world-renowned scientists and complementary cutting edge technologies is driving new innovations like never before, offering better solutions for accelerating cancer research. We at SCIEX are thrilled to be a part of this effort."

    *published in Nature Medicine


    Digital Edition

    Lab Asia 32.1 Feb 2025

    February 2025

    Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...

    View all digital editions

    Events

    SPS Smart Production Solutions Guangzhou

    Feb 25 2025 Guanghzou, China

    SmartLab Exchange

    Feb 25 2025 Amsterdam, Netherlands

    Nepal Lab

    Feb 27 2025 Kathmandu, Nepal

    PITTCON 2025

    Mar 01 2025 Boston, MA, USA

    IFPAC 2025

    Mar 02 2025 Bethesda, MD, USA

    View all events

    Redirecting you now.
    Labmate Awards Nominations - Open
    The Labmate Awards for Excellence 2025 seek to recognise innovation, quality and achievement wherever it occurs within the laboratory sector. Launching this year the Labmate Awards for Excellence 2025 will have eleven voting categories chosen to reflect the broad range of noteworthy contributions that have been made across our industry in the past 12 months. Nominate your company Now.